Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
In the form of
leukemia known as acute lymphoblastic leukemia (ALL), a group of white blood cells called lymphocytes is affected. Also called acute lymphocytic leukemia or acute lymphoid leukemia, ALL progresses very quickly and requires immediate treatment. Although ALL most commonly affects children (usually between the ages of 2 and 3), it also affects adults. Leukemias as a group are the most common form of cancer in children, accounting for about 30 percent of childhood cancers and affecting about 3,800 children each year in the United States. About 80 percent of children with leukemia have acute lymphoblastic leukemia.
Children with acute lymphobastic leukemia are treated through the
Leukemia Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center. Dana-Farber/Boston Children's has played a key role in refining treatment for childhood leukemia, resulting in today's cure rates of more than 85 percent for pediatric acute lymphoblastic leukemia (ALL).
in-depth information on acute lymphoblastic leukemia (ALL) on the Dana-Farber/Boston Children’s website, including answers to:
Appointments and Second Opinions